- from USD 19.99/mo
- Not disclosed
- Not disclosed
- —
- —
- US

Replika
by Luka Inc. · US
AI companion app marketed as a friend, not a clinical tool or medical device.
On this page
- Regulatory & Compliance0/25
No FDA clearance listed
- Clinical Integration0/13
No EHR integrations listed
- Evidence Strength9.8/20
2 peer-reviewed papers
- Vendor & Market8.4/18
Mid-tier funding and adoption
- Sentiment & Transparency2.5/18.5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/12
No FDA clearance listed
- HIPAA / SOC2 / BAA0/13
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/7
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/4
None of the top-3 EHRs covered
- Bidirectional write-back0/2
No bidirectional write-back documented
- Peer-reviewed papers10/14
2 peer-reviewed papers
- RCT / meta-analysis / systematic review0/6
No RCT, meta-analysis, or systematic review
- Funding & adoption signal8/12
Mid-tier funding and adoption
- Years in market0/6
Founded year not recorded
- Clinician sentiment (Reddit)0/14
No clinician sentiment data available
- Pricing transparency3/5
Pricing on request, no public amounts
AI companion app marketed as a friend, not a clinical tool or medical device.
Pricing from from USD 19.99/mo.
Bottom line
Replika is a consumer chat companion from Luka, Inc., sold as an AI friend on iOS and Android. The homepage does not position it for treatment, and it is not a medical device. It suits an adult who wants a conversational companion for its own sake. A clinician who wants something to hand patients as therapy has no clinical evidence to point to, and Italy's data protection authority fined the company EUR 5 million in 2025.
What is Replika and who sells it?
Luka, Inc. publishes the app and is based in San Francisco. Replika reached the public in 2017 under founder Eugenia Kuyda, though sources date the start variously to 2015, 2016 and 2017. The homepage calls it "the AI friend to do life with" and says the company built "the world's first AI companion ten years ago."
One source reports that Kuyda stepped down as CEO in early 2025 and that Dmytro Klochko has led the company since. ZoomInfo puts total funding at about $11M from Sherpa Capital, Khosla Ventures and angels.
What does the app do?
The companion keeps a memory of relationships, routines and goals across chats. It supports voice calls, sends selfies and doodles, and lets users change its appearance. The homepage shows a user count of 42,160,934, which is the vendor's own number.
What did the Italian regulator decide?
Italy's data protection authority, the Garante, fined Luka, Inc. EUR 5 million in a decision dated 10 April 2025 and announced on 19 May 2025. The stated grounds were processing personal data without a legal basis, an inadequate privacy notice, and no effective age verification. The Garante also opened a separate inquiry into how the company trains its generative AI. PYMNTS and the law firm Morri Rossetti both report the decision.
In the United States, the Young People's Alliance, Encode and the Tech Justice Law Project filed a complaint with the FTC in January 2025 alleging deceptive marketing, as Time reported. No FTC action has been announced.
How much does Replika cost?
Replika's own site shows no price. Third-party price trackers report a Pro plan at $19.99 a month or about $69.99 a year (one source says $79.99), and an Ultra plan at $29.99 a month or $119.99 a year. A lifetime plan at $299.99 appears on several sites, while one says it has been discontinued. Prices differ by region and by in-app screen.
Is there any research on it?
No efficacy trial of Replika is known. A 2022 paper in JMIR Human Factors analysed themes in how people talk with human-social chatbots, Replika among them, and describes behaviour without measuring benefit. A 2025 paper on emotionally intelligent chatbots and loneliness that mentions Replika has been retracted.
Reported complaints come from secondary blogs: memory wipes after updates, an over-aggressive age gate, level resets, the 2023 removal of NSFW features, subscription cost, and earlier reports of sexually aggressive replies and minors getting past age limits. Long-term users describe companionship in their own words, and the testimonials on the homepage are selected by the vendor.
Who is it for?
An adult who wants an always-available chat partner and treats the product as companionship. Someone considering it as therapy is outside what the vendor claims.
The verdict
Replika is a companionship product, and it is fair to judge it as one. The regulatory record in Italy is about how it handles personal data and children, which matters to a parent or a clinician whose patient is a teenager. Nothing published shows it treats anything.
Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
Paid plans span USD 19.99 to USD 29.99 per month per provider, depending on tier.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Free | — | — | Free download. replika.com shows no prices and /pricing returns 404. |
| Pro, monthly (third-party figure) | USD 19.99 | — | Third-party figure, not on replika.com. Prices vary by region and in-app screen. |
| Pro, yearly (third-party figure) | — | USD 69.99 | Third-party figure, not on replika.com. One source lists $79.99. |
| Ultra (third-party figure) | USD 29.99 | — | Third-party figure, not on replika.com. $29.99 per month or $119.99 per year. A lifetime plan ($299.99) is reported by some sites. One says it was discontinued. |
Source: vendor pricing page. Last checked October 15, 2026.
What the literature says
2 peer-reviewed studies indexed on PubMed evaluate Replika in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.
- Chatbots' Empathetic Conversations and Responses: A Qualitative Study of Help‑Seeking Queries on Depressive Moods Across 8 Commercial Conversational Agents.
- Chin H, Baek G, Cha C, et al.· JMIR Form Res· 2025
- While recent studies showed the potential of conversational agents (CAs) to help alleviate depressive moods, the dynamics of user-chatbot interactions in mental health support remain underexplored. We examine real-world conversations between users and chatbots on depression-related topics to identify patterns in how users seek help and how chatbots provide therapeutic support. We analyzed the responses of 8 commercial chatbots to user queries about depressive moods, examining whether they incorporated therapeutic communication techniques, such as empathy. Our method has 2 parts. First, we ana…
- Assessing the Topics and Motivating Factors Behind Human-Social Chatbot Interactions: Thematic Analysis of User Experiences.
- Ta-Johnson VP, Boatfield C, Wang X, et al.· JMIR Hum Factors· 2022
- Although social chatbot usage is expected to increase as language models and artificial intelligence improve, very little is known about the dynamics of human-social chatbot interactions. Specifically, there is a paucity of research examining why human-social chatbot interactions are initiated and the topics that are discussed. We sought to identify the motivating factors behind initiating contact with Replika, a popular social chatbot, and the topics discussed in these interactions. A sample of Replika users completed a survey that included open-ended questions pertaining to the reasons why…




